Benzinga | Jan 7, 2022 01:04PM EST

B of A Securities Upgrades Singular Genomics Systems to Buy, Announces $21 Price Target

B of A Securities analyst Michael Ryskin upgrades Singular Genomics Systems (NASDAQ:OMIC) from Neutral to Buy and announces $21 price target.